Sengupta, S., and Harris, C. C. (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6, 44-55.

Sharp, D. A., Kratowicz, S. A., Sank, M. J., and George, D. L. (1999). Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem 274, 38189-38196.

Shenoy, S. K., McDonald, P. H., Kohout, T. A., and Lefkowitz, R. J. (2001). Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294, 1307-1313.

Shieh, S. Y„ Ahn, J., Tamai, K., Taya, Y„ and Prives, C. (2000). The human homologs of checkpoint kinases Chkl and Cdsl (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14, 289-300.

Shikama, N., Lee, C. W., France, S., Delavaine, L., Lyon, J., Krstic-Demonacos, M., and La Thangue, N. B. (1999). A novel cofactor for p300 that regulates the p53 response. Mol Cell 4, 365-376.

Smith, J. (2002). Human Sir2 and the 'silencing' of p53 activity. Trends Cell Biol 12, 404.

Smith, P. D., Crossland, S., Parker, G., Osin, P., Brooks, L., Waller, J., Philp, E., Crompton, M. R., Gusterson, B. A., Allday, M. J., and Crook, T. (1999). Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18, 2451-2459.

Soengas, M. S., Alarcon, R. M., Yoshida, H., Giaccia, A. J., Hakem, R„ Mak, T. W„ and Lowe, S. W. (1999). Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156-159.

Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., and Jochemsen, A. G. (2001). Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep 2, 1029-1034.

Sterner, D. E., and Berger, S. L. (2000). Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64, 435-459.

Sugars, K. L., Budhram-Mahadeo, V., Packham, G., and Latchman, D. S. (2001). A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res 29, 4530-4540.

Taylor, W. R., and Stark, G. R. (2001). Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815. Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002). p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53.

Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L., and Weinberg, R. A. (2001). hSIR2(SIRTl) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159.

Vousden, K. H. (2000). p53: death star. Cell 103, 691-694. Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R„ Krantz, I. D„ Kao, G., Gan, D. D., Zhou, J. Y„ Muschel, R„ et al. (1997). KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17, 141-143.

Wu, K., Chen, A., Tan, P., and Pan, Z. Q. (2002). The Nedd8-conjugated ROC1-CUL1 core ubiquitin ligase utilizes Nedd8 charged surface residues for efficient polyubiquitin chain assembly catalyzed by Cdc34. J Biol Chem 277, 516-527. Wu, X., Bayle, J. H., Olson, D„ and Levine, A. J. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7, 1126-1132.

Wunderlich, M., Ghosh, M., Weghorst, K., and Berberich, S. J. (2004). MdmX Represses E2F1 Transactivation. Cell Cycle 3, 472-478.

Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P., and Lain, S. (2001). Different effects of pl4ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20, 4972-4983. Xirodimas, D. P., Saville, M. K., Bourdon, J. C., Hay, R. T., and Lane, D. P. (2004). Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118, 83-97. Yam, C. H., Siu, W. Y., Arooz, T„ Chiu, C. H„ Lau, A., Wang, X. Q„ and Poon, R. Y. (1999). MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins. Cancer Res 59, 5075-5078.

Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F.,

Volinia, S., Ronai, Z., Blandino, G., Schneider, C., and Del Sal, G. (2002). The prolyl isomerase Pinl reveals a mechanism to control p53 functions after genotoxic insults. Nature 419, 853-857.

Zhang, Y„ Wolf, G. W., Bhat, K„ Jin, A., Allio, T„ Burkhart, W. A., and Xiong, Y. (2003). Ribosomal protein Lll negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23, 8902-8912.

Zhao, L. Y., and Liao, D. (2003). Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. J Virol 77, 13171-13181.

Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G„ Gu, L., Tang, X., Lu, K. P., and Xiao, Z. X. (2002). The prolyl isomerase Pinl is a regulator of p53 in genotoxic response. Nature 419, 849-853.

Zilfou, J. T„ Hoffman, W. H„ Sank, M„ George, D. L., and Murphy, M. (2001). The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol Cell Biol 21, 3974-3985.

0 0

Post a comment